Thus, 1α,25-(OH)2D3 enhances the osteoclast-inductive capacity by increasing the RANKL/OPG ratio in normal hDFCs and this effect is eliminated by RUNX2 mutation in CCD hDFCs. The gene discussed is RUNX2; the disease is cleidocranial dysplasia 1.